PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE AND/OR CORNEAL AND CONJUNCTIVAL LESION

摘要

Disclosed is a pharmaceutical composition for the treatment of dry eye and/or corneal/conjunctival disorders.  The pharmaceutical composition comprises a human serum albumin as an active ingredient, wherein the human serum albumin is produced by using a recombinant yeast produced by transforming an yeast with a gene encoding the human serum albumin.  Also disclosed is a method for the treatment of dry eye and/or corneal/conjunctival disorders, which comprises administering an effective amount of a human serum albumin to a patient who needs the treatment of dry eye and/or corneal/conjunctival disorders, wherein the human serum albumin is produced by using a recombinant yeast produced by transforming an yeast with a gene encoding the human serum albumin.